Thursday, March 28, 2024
Advertisement
  1. You Are At:
  2. News
  3. Good News
  4. Swiss government inks deal with Moderna for 4.5 million doses of COVID-19 vaccine

Swiss government inks deal with Moderna for 4.5 million doses of COVID-19 vaccine

 The Federal Office of Public Health said the agreement aims to guarantee Switzerland early access to the vaccine of Moderna and is one of the first such deals by any government with the company.

India TV News Desk Edited by: India TV News Desk Geneva Published on: August 07, 2020 17:55 IST
Swiss government inks deal with Moderna for 4.5 million doses of COVID-19 vaccine
Image Source : AP

Swiss government inks deal with Moderna for 4.5 million doses of COVID-19 vaccine

The Swiss federal government has struck a deal with Moderna to supply Switzerland with 4.5 million doses of a COVID-19 vaccine if the US biotech firm successfully develops one. The Federal Office of Public Health said the agreement aims to guarantee Switzerland early access to the vaccine of Moderna and is one of the first such deals by any government with the company, Associated Press reported.

The federal government want to ensure that the Swiss population has rapid access to a safe and effective COVID-19 vaccine, an office statement said on Thursday. At the same time, Switzerland is supporting multilateral projects for the fair distribution of a future vaccine.

The agreement comes amid a thorny debate about who should get a safe and effective COVID-19 vaccine first.

The Moderna deal would make it possible to vaccinate 2.25 million people, because expectations are that two doses would be needed, it said. That would be enough for more than a fourth of the wealthy Alpine country’s population of about 8.2 million.

The Swiss government is also in talks with other vaccine companies and has already allocated 300 million Swiss francs (nearly $330 million) for purchases of COVID-19 vaccine. It did not specify the value of the Moderna deal. Early trials found the experimental Moderna vaccine, developed with the US National Institutes of Health, revved up people’s immune systems. A larger study that’s expected to involve 30,000 people began last month and hopes to show the vaccine is strong enough to protect against the coronavirus.

(With inputs from AP)

Advertisement

Read all the Breaking News Live on indiatvnews.com and Get Latest English News & Updates

Advertisement
Advertisement
Advertisement
Advertisement